Triple Negative Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Triple-Negative Breast Cancer

Featuring perspectives from Drs Sara Hurvitz, Rita Nanda and Melinda Telli, moderated by Dr Hope Rugo, including the following topics: Therapeutic strategies for patients with localized triple-negative breast cancer (TNBC) (0:00) Current and future role of PARP inhibitors in metastatic TNBC (28:28) Optimal integration of immune checkpoint inhibitors into the management of TNBC (52:52) Other novel treatment options and investigational strategies for TNBC (1:17:52) CME information and select publications